|
|
||||||||
J Thorac Cardiovasc Surg 1998;115:990-994
© 1998 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
From the Division of Cardiothoracic Surgery, The University of Pittsburgh Medical Center, Pittsburgh, Pa.
Read at the Twenty-second Annual Meeting of The Western Thoracic Surgical Association, Maui, Hawaii, June 26-29, 1996.
Received for publication March 10, 1997. Revisions requested May 21, 1997; revisions received Dec. 11, 1997. Accepted for publication Dec. 11, 1997. Address for reprints: James S. Gammie, MD, University of Pittsburgh, Division of Cardiothoracic Surgery, C-700 Scaife, 200 Lothrop St., Pittsburgh, PA 15213.
Abstract
Objectives: To assess the effect of cardiopulmonary bypass on allograft function and recipient survival in double-lung transplantation.
Methods: Retrospective review of 94 double-lung transplantations.
Results: Cardiopulmonary bypass was used in 37 patients (CPB); 57 transplantations were accomplished without bypass (no-CPB). Bypass was routinely used for patients with pulmonary hypertension (n = 27) and for two recipients undergoing en bloc transplantation. Cardiopulmonary bypass was required in eight (12.3%) of the remaining 65 patients. Mean ischemic time was longer in the CPB group (346 vs 315 minutes, p = 0.04). The CPB group required more perioperative blood (11.4 vs 6.0 units, p = 0.01). Allograft function, assessed by the arterial/alveolar oxygen tension ratio, was better in the no-CPB group at 12 and 24 hours after operation (0.54 vs 0.39 at 12 hours, p = 0.002; and 0.63 vs 0.38 at 24 hours, p = 0.001). The CPB group had more severe pulmonary infiltrates at both 1 and 24 hours (p = 0.005). Diffuse alveolar damage was more common in the CPB group (69% vs 35%, p = 0.002). Median duration of intubation was longer in the CPB group (10 days) than in the no-CPB group (2 days, p = 0.002). The 30-day mortality rate (13.5% vs 7.0% in the CPB and no-CPB groups) and 1-year survival (65% vs 67%, CPB and no-CPB) were not significantly different.
Conclusions: In the absence of pulmonary hypertension, cardiopulmonary bypass is only occasionally necessary in double-lung transplantation. Bypass is associated with substantial early allograft dysfunction after transplantation.
This article has been cited by other articles:
![]() |
B. Baez and M. Castillo Anesthetic Considerations for Lung Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 122 - 127. [Abstract] [PDF] |
||||
![]() |
F. Venuta, G. Mazzesi, F. Francioni, M. Anile, M. Di Stasio, V. Liparulo, C. Ricella, and G. F. Coloni Use of an apical heart suction device to expose the left pulmonary veins during transsternal pneumonectomy. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1369 - 1371. [Full Text] [PDF] |
||||
![]() |
H. B. Bittner, C. Binner, S. Lehmann, T. Kuntze, A. Rastan, and F. W. Mohr Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saitoh, M. Tsuchida, T. Koike, K. Satoh, M. Haga, T. Aoki, S.-i. Toyabe, and J.-i. Hayashi Ultrafiltration attenuates cardiopulmonary bypass-induced acute lung injury in a canine model of single-lung transplantation J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Varghese Jr Invited commentary Ann. Thorac. Surg., August 1, 2006; 82(2): 478 - 479. [Full Text] [PDF] |
||||
![]() |
A. Mathur, M. Baz, E. D. Staples, M. Bonnell, J. M. Speckman, P. J. Hess Jr, C. T. Klodell, D. G. Knauf, L. L. Moldawer, and T. M. Beaver Cytokine profile after lung transplantation: correlation with allograft injury. Ann. Thorac. Surg., May 1, 2006; 81(5): 1844 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Lau, D. M. Hoganson, B. F. Meyers, R. J. Damiano Jr, and G. A. Patterson Use of an Apical Heart Suction Device for Exposure in Lung Transplantation Ann. Thorac. Surg., April 1, 2006; 81(4): 1524 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miranda, R. Zink, and M. McSweeney Anesthesia for Lung Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2005; 9(3): 205 - 212. [Abstract] [PDF] |
||||
![]() |
K. Parekh, B. F. Meyers, G. A. Patterson, T. J. Guthrie, E. P. Trulock, R. J. Damiano Jr, and N. Moazami Outcome of lung transplantation for patients requiring concomitant cardiac surgery J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 859 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Szeto, D. Kreisel, G. C. Karakousis, A. Pochettino, D. H. Sterman, R. M. Kotloff, S. M. Arcasoy, D. A. Zisman, N. P. Blumenthal, R. J. Gallop, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Vricella, J. M. Karamichalis, S. Ahmad, R. C. Robbins, R. I. Whyte, and B. A. Reitz Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the stanford experience Ann. Thorac. Surg., July 1, 2002; 74(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |